Open AccessRespiratory viral testing and antibacterial treatment in patients hospitalized with community-acquired pneumonia
Author(s) -
Michael Klompas,
Peter B. Imrey,
Pei-Chun Yu,
Chanu Rhee,
Abhishek Deshpande,
Sarah Haessler,
Marya D. Zilberberg,
Michael B. Rothberg
Publication year - 2020
Publication title -
infection control and hospital epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.243
H-Index - 138
eISSN - 1559-6834
pISSN - 0899-823X
DOI - 10.1017/ice.2020.1312
Subject(s) - rhinovirus , medicine , pneumonia , viral pneumonia , community acquired pneumonia , bacterial pneumonia , respiratory system , virus , antimicrobial , immunology , covid-19 , microbiology and biotechnology , biology , infectious disease (medical specialty) , disease
Viruses are more common than bacteria in patients hospitalized with community-acquired pneumonia. Little is known, however, about the frequency of respiratory viral testing and its associations with antimicrobial utilization.